Open access · CC-BY
via OpenAlex
Targeting immune dysfunction in aging
Simone Borgoni, Ksenia S. Kudryashova, Ksenia Burka, João Pedro de Magalhães
Ageing Research Reviews · 2021 · ▲ 219 citations
Abstract
Human aging is a multifactorial phenomenon that affects numerous organ systems and cellular processes, with the immune system being one of the most dysregulated. Immunosenescence, the gradual deterioration of the immune system, and inflammaging(definition), a chronic inflammatory state that persists in the elderly, are among the plethora of immune changes that occur during aging. Almost all populations of immune cells change with age in terms of numbers and/or activity. These alterations are in general highly detrimental, resulting in an increased susceptibility to infections, reduced healing abilities, and altered homeostasis that promote the emergence of age-associated diseases such as cancer, diabetes, and other diseases associated with inflammation. Thanks to recent developments, several strategies have been proposed to target central immunological processes or specific immune subpopulations affected by aging. These therapeutic approaches could soon be applied in the clinic to slow down or even reverse specific age-induced immune changes in order to rejuvenate the immune system and prevent or reduce the impact of various diseases. Due to its systemic nature and interconnection with all the other systems in the body, the immune system is an attractive target for aging intervention because relatively targeted modifications to a small set of cells have the potential to improve the health of multiple organ systems. Therefore, anti-aging immune targeting therapies could represent a potent approach for improving healthspan(definition). Here, we review aging changes in the major components of the immune system, we summarize the current immune-targeting therapeutic approaches in the context of aging and discuss the future directions in the field of immune rejuvenation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.arr.2021.101410
- Canonical
- link ↗
- Fetched
- 2026-06-08 MST
Cite this
APA
Borgoni, S., Kudryashova, K.S., Burka, K., & Magalhães, J.P.D. (2021). Targeting immune dysfunction in aging. <em>Ageing Research Reviews</em>. https://doi.org/10.1016/j.arr.2021.101410
Vancouver
Borgoni S, Kudryashova KS, Burka K, Magalhães JPD. Targeting immune dysfunction in aging. Ageing Research Reviews. 2021. doi:10.1016/j.arr.2021.101410.
BibTeX
@article{simone2021Target,
title = {Targeting immune dysfunction in aging},
author = {Simone Borgoni and Ksenia S. Kudryashova and Ksenia Burka and João Pedro de Magalhães},
journal = {Ageing Research Reviews},
year = {2021},
doi = {10.1016/j.arr.2021.101410},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Immunology 2018
Open access · CC-BY
Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
Frontiers in Immunology 2019
Open access · CC-BY
Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention
Revista de investigaci�n Cl�nica 2016
Open access · CC-BY
The Role of Immunosenescence in the Development of Age-Related Diseases
Mechanisms of Ageing and Development 2020
Open access · CC-BY
Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease
International Journal of Molecular Sciences 2019
Open access · CC-BY
mTOR and Aging: An Old Fashioned Dress
Sub-cellular biochemistry/Subcellular biochemistry 2019
Citation only